İnözü, M. Et Al. 2022. Eculizumab for bevacizumab induced thrombotic microangiopathy: A case report. Pediatric Hematology Oncology Journal , vol.7, no.4 , 169-172.

İnözü, M., Özlü, S. G., Özyörük, D., KİREMİTCİ, S., Çakmakçı, S., Avcı, B., ... Özdemir, S. İ.(2022). Eculizumab for bevacizumab induced thrombotic microangiopathy: A case report. Pediatric Hematology Oncology Journal , vol.7, no.4, 169-172.

İnözü, Mihriban Et Al. "Eculizumab for bevacizumab induced thrombotic microangiopathy: A case report," Pediatric Hematology Oncology Journal , vol.7, no.4, 169-172, 2022

İnözü, Mihriban Et Al. "Eculizumab for bevacizumab induced thrombotic microangiopathy: A case report." Pediatric Hematology Oncology Journal , vol.7, no.4, pp.169-172, 2022

İnözü, M. Et Al. (2022) . "Eculizumab for bevacizumab induced thrombotic microangiopathy: A case report." Pediatric Hematology Oncology Journal , vol.7, no.4, pp.169-172.

@article{article, author={Mihriban İnözü Et Al. }, title={Eculizumab for bevacizumab induced thrombotic microangiopathy: A case report}, journal={Pediatric Hematology Oncology Journal}, year=2022, pages={169-172} }